Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 880
Filter
1.
Arch. argent. pediatr ; 119(4): e315-e321, agosto 2021. tab
Article in English, Spanish | LILACS, BINACIS | ID: biblio-1281006

ABSTRACT

La prematiridad fue aumentando la supervivencia desde hace varios años, y eso produce, sobre todo, una preocupación en los prematuros nacidos antes de las 28 semanas de gestación. El tiempo del clampeo del cordón umbilical puede generar diversos trastornos, principalmente, cuando se realiza temprano (10-15 segundos). Ya desde hace 20 años, a través de varias investigaciones, se pudieron demostrar los notorios beneficios del clampeo demorado del cordón (de 2 a 3 minutos). Esta práctica fue instalada en la asistencia obstétrica y neonatal por las recomendaciones de sociedades científicas y de las revisiones sistemáticas, que señalaron las sólidas evidencias que apoyaban esta conducta para prematuros. En esta revisión, se describen los artículos más relevantes en los últimos años, que sustentan notoriamente la aplicación del clampeo demorado del cordón versus el clampeo temprano. Asimismo, esta práctica genera una disminución de los trastornos graves en prematuros.


For several years now, the survival of preterm infants has been increasing, which has shifted our concern to preterm infants born before 28 weeks of gestation in particular. The timing of umbilical cord clamping may lead to several disorders, especially when done early (10-15 seconds). In the last two decades, several investigations have shown the considerable benefits of delayed cord clamping (2-3 minutes). Delayed cord clamping has been practiced in obstetrics and neonatal care based on the recommendations made by scientific societies and in systematic reviews, which have provided solid evidence to support this practice in preterm infants. This review describes the most relevant articles from the last years, which strongly support the use of delayed cord clamping versus early cord clamping. In addition, this practice reduces the rate of severe disorders in preterm infants.


Subject(s)
Humans , Male , Female , Pregnancy , Infant, Newborn , Umbilical Cord , Placental Circulation/physiology , Ligation , Time Factors , Infant, Premature
2.
Alerta (San Salvador) ; 4(3): 102-98, jul. 29, 2021. ilus
Article in Spanish | LILACS, BISSAL | ID: biblio-1282073

ABSTRACT

El síndrome de cordón umbilical corto es una anomalía poco común e incompatible con la vida que se asocia a defectos de la pared anterior del feto, cordón umbilical corto o ausente y anomalías de los miembros. Esta entidad es la más severa y más infrecuente entre los defectos de la pared anterior del abdomen, con una incidencia de 1 en 14 000 nacimientos. Se presenta el caso de un recién nacido de término, de sexo indeterminado, producto de primer embarazo, de parto abdominal. A las 28 semanas de gestación se diagnosticó un defecto en pared abdominal anterior y una imagen quística de columna vertebral por ultrasonografía. Al nacimiento se observaron los órganos abdominales expuestos, el cordón umbilical grueso, de 10 cm de longitud, eventración de intestinos e hígado y cifoescoliosis marcada, ausencia de genitales externos y de ano, un remanente de miembro inferior derecho y miembro inferior izquierdo completo con pie equinovaro. Se le dio apoyo ventilatorio y falleció a los 15 minutos de vida


Short umbilical cord syndrome is a rare and life-incompatible abnormality associated with fetal anterior wall defects, absent or short umbilical cord, and limb abnormalities. This entity is the most severe and rarest of anterior abdominal wall defects, with an incidence of 1 in 14,000 births. We present the case of a full-term newborn, of undetermined sex, product of first pregnancy, of abdominal delivery. At 28 weeks' gestation, an anterior abdominal wall defect and a cystic image of the spine were diagnosed by ultrasonography. At birth, the exposed abdominal organs, the thick umbilical cord, 10 cm in length, eventration of the intestines and liver and marked kyphoscoliosis, absence of external genitalia and anus, a remnant of the right lower limb and complete left lower limb with foot were observed. equinovarus. Ventilatory support was given and died at 15 minutes of life


Subject(s)
Syndrome , Umbilical Cord , Parturition , Intestines
3.
Biomédica (Bogotá) ; 41(1): 8-16, ene.-mar. 2021. tab, graf
Article in Spanish | LILACS | ID: biblio-1249054

ABSTRACT

Resumen. La encefalopatía hipóxico-isquémica es una causa frecuente e importante de daño neurológico en recién nacidos a término y prematuros. Un evento centinela de esta condición es la vasa previa, específicamente cuando existe anormalidad de la placenta como la inserción "velamentosa" del cordón umbilical. Algunos reportes evidencian la asociación entre estas dos condiciones, pero son escasos los que dan cuenta del proceso de recuperación y del pronóstico neurológico de los niños afectados por ellas. Se presenta el caso de un paciente, con antecedentes de inserción "velamentosa" del cordón umbilical y encefalopatía hipóxico-isquémica, que recibió hipotermia terapéutica (cool cap). Se describe su proceso de rehabilitación neurológica y se calculó el porcentaje de probabilidad de presentar esta condición frente a la población sin estos factores. El niño tenía cinco años y el puntaje en su prueba de Apgar fue de 0 al minuto y de 2 a los 15 minutos. Desarrolló encefalopatía hipóxico-isquémica grave secundaria a una inserción "velamentosa" del cordón umbilical sin diagnóstico prenatal, con gran compromiso neurológico y multisistémico inicial. El proceso de recuperación incluyó el manejo inicial multidisciplinario en la unidad de cuidados intensivos neonatales y el inicio temprano de habilitación neurológica. Hoy el niño está escolarizado y en terapia integral, no presenta deficiencias motoras ni sensoriales en el examen físico, aunque la prueba neuropsicológica sugiere un riesgo de trastorno por déficit de atención e hiperactividad. Habitualmente, los niños con encefalopatía hipóxico-isquémica grave presentan discapacidad por deficiencias motoras, cognitivas o conductuales. El haber recibido hipotermia terapéutica y un manejo estructurado de rehabilitación redujo en gran medida las deficiencias esperadas y ha promovido un satisfactorio desarrollo físico y neurológico.


Abstract. Hypoxic-ischemic encephalopathy is a frequent and important cause of neurological problems in term and preterm newborns. A sentinel event of this entity is the vasa previa, specifically when there is an abnormality of the placenta such as a velamentous cord insertion. Some reports have shown the association between these two entities, but those regarding the recovery process and the neurological prognosis of children with both conditions are scarce. We present the case of a patient with a history of velamentous cord insertion and hypoxic-ischemic encephalopathy who received therapeutic hypothermia (cool cap). We describe his neurological rehabilitation process and we calculated the percentage of probability of presenting this condition compared to the population without these factors. The patient was a five-year-old boy with an Apgar index at birth equal to zero at one minute and equal to two at fifteen minutes who developed severe hypoxic-ischemic encephalopathy secondary to a velamentous cord insertion without prenatal diagnosis and a marked initial neurological and multisystemic compromise. The recovery process included early multidisciplinary management in the neonatal intensive care unit and a focus on early neurological habilitation. The patient is currently in school and he undergoes comprehensive therapies; on physical examination, he presents no motor or sensory deficiencies. His neuropsychological test suggests the risk of attention deficit hyperactivity disorder. Children with severe hypoxic-ischemic encephalopathy usually have disabilities due to motor, cognitive, and/or behavioral deficiencies. Having received therapeutic hypothermia and a structured rehabilitation process greatly reduced the expected deficiencies according to prognosis and have promoted satisfactory physical and neurological development.


Subject(s)
Umbilical Cord , Hypoxia-Ischemia, Brain , Hypothermia, Induced , Neurological Rehabilitation
4.
Article in Chinese | WPRIM | ID: wpr-879856

ABSTRACT

OBJECTIVE@#To compare the effect of delayed cord clamping (DCC) versus umbilical cord milking (UCM) on cerebral blood flow in preterm infants.@*METHODS@#This was a single-center, prospective, double-blind, randomized controlled trial. A total of 46 preterm infants, with a gestational age of 30-33@*RESULTS@#A total of 21 preterm infants in the DCC group and 23 in the UCM group were included in the statistical analysis. There was no significant difference in PSV, EDV, and RI between the two groups at all time points after birth (@*CONCLUSIONS@#DCC and UCM have a similar effect on cerebral hemodynamics in preterm infants with a gestational age of 30-33


Subject(s)
Constriction , Hemodynamics , Humans , Infant , Infant, Newborn , Infant, Premature , Prospective Studies , Umbilical Cord
5.
Article in Chinese | WPRIM | ID: wpr-879807

ABSTRACT

OBJECTIVE@#To study the association of different maternal and infant factors with the number of total nucleated cells and CD34@*METHODS@#A prospective study was performed for the umbilical cord blood samples of 130 neonates who were born in Dalian Women and Children's Medical Center from June 2019 to January 2020, with a male/female ratio of 1:1. Related perinatal information was collected, including maternal age and blood type, presence or absence of gestational diabetes or gestational hypertension, pregnancy method, mode of delivery, singleton pregnancy/twin pregnancy, body weight and sex of neonates, Apgar score after birth, and the conditions of placenta, amniotic fluid, and umbilical cord.@*RESULTS@#The neonates were grouped according to maternal blood type, gestational diabetes, gestational hypertension, pregnancy method, mode of delivery, singleton pregnancy/ twin pregnancy, sex of neonates, Apgar score after birth, placental morphology, meconium staining of amniotic fluid, and umbilical cord around the neck. The comparison between groups showed no significant differences in the numbers of total nucleated cells and CD34@*CONCLUSIONS@#The number of CD34


Subject(s)
Antigens, CD34 , Female , Fetal Blood , Hematopoietic Stem Cell Transplantation , Hematopoietic Stem Cells , Humans , Infant , Infant, Newborn , Male , Pregnancy , Prospective Studies , Umbilical Cord
6.
Clinics ; 76: e2604, 2021. tab, graf
Article in English | LILACS | ID: biblio-1249585

ABSTRACT

OBJECTIVES: The coronavirus disease (COVID-19) outbreak has catastrophically threatened public health worldwide and presented great challenges for clinicians. To date, no specific drugs are available against severe acute respiratory syndrome coronavirus 2. Mesenchymal stem cells (MSCs) appear to be a promising cell therapy owing to their potent modulatory effects on reducing and healing inflammation-induced lung and other tissue injuries. The present pilot study aimed to explore the therapeutic potential and safety of MSCs isolated from healthy cord tissues in the treatment of patients with COVID-19. METHODS: Twelve patients with COVID-19 treated with MSCs plus conventional therapy and 13 treated with conventional therapy alone (control) were included. The efficacy of MSC infusion was evaluated by changes in oxygenation index, clinical chemistry and hematology tests, immunoglobulin (Ig) levels, and pulmonary computerized tomography (CT) imaging. The safety of MSC infusion was evaluated based on the occurrence of allergic reactions and serious adverse events. RESULTS: The MSC-treated group demonstrated significantly improved oxygenation index. The area of pulmonary inflammation decreased significantly, and the CT number in the inflammatory area tended to be restored. Decreased IgM levels were also observed after MSC therapy. Laboratory biomarker levels at baseline and after therapy showed no significant changes in either the MSC-treated or control group. CONCLUSION: Intravenous infusion of MSCs in patients with COVID-19 was effective and well tolerated. Further studies involving a large cohort or randomized controlled trials are warranted.


Subject(s)
Humans , Coronavirus Infections , Mesenchymal Stem Cell Transplantation , Mesenchymal Stem Cells , Umbilical Cord , Pilot Projects , Betacoronavirus
7.
Rev. gaúch. enferm ; 42: e20200241, 2021. tab, graf
Article in English | LILACS, BDENF | ID: biblio-1251774

ABSTRACT

ABSTRACT Objective Measure umbilical cord pulsatility time and evaluate correlation/association with maternal and neonatal characteristics. Method Cross-sectional study, with 76 binomials, carried out in 2017, in a maternity hospital in Alagoas. Analysis with Pearson or Spearman correlation test and Mann-Whitney or Kruskal-Wallis test. Results Sixty-two parturients and their newborns participated of the research. The women had a gestational age ≥ 37 weeks, natural cephalic birth, without distortions. The newborns had average weight of 3326.29g, mostly male. The umbilical cord pulsatility time was 285.48s. There is a correlation between umbilical cord pulsatility time and placental delivery time (p<0.001). Other correlations/associations were not significant. Conclusion It suggested using a correlation between pulsatility time and placental delivery time in clinical decision making for good practices in childbirth assistance.


RESUMEN Objetivo Medir tiempo de pulsatilidad del cordón umbilical y evaluar la correlación/asociación con las características maternas y neonatales. Método Estudio transversal, con 76 pares, realizado en 2017, en maternidad en Alagoas. Análisis con la prueba de correlación de Pearson o Spearman y la prueba de Mann-Whitney o Kruskal-Wallis. Resultados Sesenta y dos mujeres en trabajo de parto y sus recién nacidos participaron. Las mujeres tenían edad gestacional ≥ 37 semanas, parto cefálico normal, sin distorsiones. Los recién nacidos tenían peso promedio de 3326.29g, la mayoría de ellos varones. Tiempo de pulsatilidad del cordón umbilical fue de 285.48s. Había correlación entre el tiempo de pulsatilidad del cordón umbilical y el momento del parto placentario (p<0,001). Otras correlaciones/asociaciones no fueron significativas. Conclusión Sugiere una correlación entre el tiempo de pulsatilidad y el tiempo de parto placentario para las buenas prácticas en la atención del parto.


RESUMO Objetivo Mensurar tempo de pulsatilidade do cordão umbilical e avaliar correlação/associação com característica maternas e neonatais. Método Estudo transversal, com 76 binômios, realizado no ano de 2017, em maternidade de Alagoas. Análise com teste de correlação de Pearson ou Spearman e teste de Mann-Whitney ou Kruskal-Wallis. Resultados Sessenta e duas parturientes e seus recém-nascidos participaram da pesquisa. As mulheres tinham idade gestacional ≥ 37 semanas, parto normal cefálico, sem distorcias. Os recém-nascidos tinham peso médio de 3326,29g, maioria do sexo masculino. O tempo de pulsatilidade do cordão umbilical foi 285,48s. Há correlação entre tempo de pulsatilidade do cordão umbilical e tempo de dequitação da placenta (p<0,001). Demais correlações/associações não foram significativas. Conclusão Sugere-se o uso correlação entre tempo de pulsatilidade e tempo de dequitação da placenta na tomada de decisão clínica para boas práticas na assistência ao parto.


Subject(s)
Humans , Female , Pregnancy , Placenta/physiology , Umbilical Cord/embryology , Natural Childbirth , Obstetric Nursing , Brazil , Epidemiology, Descriptive , Cross-Sectional Studies , Hospitals, Maternity
8.
Article in Chinese | WPRIM | ID: wpr-879535

ABSTRACT

OBJECTIVE@#To compare the mRNA level of cell proliferation-related genes Twist1, SIRT1, FGF2 and TGF-β3 in placenta mesenchymal stem cells (PA-MSCs), umbilical cord mensenchymals (UC-MSCs) and dental pulp mesenchymal stem cells (DP-MSCs).@*METHODS@#The morphology of various passages of PA-MSCs, UC-MSCs and DP-MSCs were observed by microscopy. Proliferation and promoting ability of the three cell lines were detected with the MTT method. Real-time PCR (RT-PCR) was used to determine the mRNA levels of Twist1, SIRT1, FGF2, TGF-β3.@*RESULTS@#The morphology of UC-MSCs and DP-MSCs was different from that of PA-MSCs. Proliferation ability and promoting ability of the PA-MSCs was superior to that of UC-MSCs and DP-MSCs. In PA-MSCs, expression level of Twist1 and TGF-β3 was the highest and FGF2 was the lowest. SIRT1 was highly expressed in UC-MSCs. With the cell subcultured, different expression levels of Twist1, SIRT1, FGF2, TGF-β3 was observed in PA-MSCs, UC-MSCs and DP-MSCs.@*CONCLUSION@#Up-regulated expression of the Twist1, SIRT1 and TGF-β3 genes can promote proliferation of PA-MSCs, UC-MSCs and DP-MSCs, whilst TGF-β3 may inhibit these. The regulatory effect of Twist1, SIRT1, FGF2 and TGF-β3 genes on PA-MSCs, UC-MSCs and DP-MSCs are different.


Subject(s)
Cell Differentiation , Cell Proliferation/genetics , Cells, Cultured , Dental Pulp/cytology , Female , Fibroblast Growth Factor 2/genetics , Humans , Mesenchymal Stem Cells/cytology , Nuclear Proteins/genetics , Placenta/cytology , Pregnancy , Sirtuin 1/genetics , Transforming Growth Factor beta3/genetics , Twist-Related Protein 1/genetics , Umbilical Cord/cytology
10.
Medicentro (Villa Clara) ; 24(1): 198-206, ene.-mar. 2020. graf
Article in Spanish | LILACS | ID: biblio-1091086

ABSTRACT

RESUMEN La rotura de vasa previa es una afección infrecuente que aparece cuando el cordón umbilical tiene una inserción velamentosa y los vasos fetales desprotegidos, que al carecer de la gelatina de Wharton, discurren a través de las membranas, lo que los hace especialmente vulnerables a la rotura o desgarros. Los factores de riesgo más relevantes son: la gestación gemelar monocorial, las gestaciones conseguidas mediante técnicas de reproducción asistida y las anomalías de inserción placentaria. La rotura de la vasa previa puede llevar a: una hemorragia fetal aguda, un choque hipovolémico, una asfixia fetal y a la muerte perinatal. El estudio ecográfico de la placenta y el empleo del Doppler color tienen gran importancia para lograr el diagnóstico precoz de las pacientes en riesgo, el cual constituye la premisa fundamental para lograr disminuir la morbilidad y mortalidad fetal y neonatal.


ABSTRACT Ruptured vasa previa is an uncommon condition that appears when the umbilical cord has a velamentous insertion and the unprotected fetal vessels, which, in the absence of Wharton's jelly, run through membranes making them especially vulnerable to rupture or tears. The most relevant risk factors are: monochorionic twin pregnancy, pregnancies achieved through assisted reproductive techniques and abnormal placental cord insertion. Ruptured vasa previa can lead to: acute fetal hemorrhage, hypovolemic shock, fetal asphyxia and perinatal death. The ultrasound study of the placenta and the use of color Doppler ultrasound are of great importance to achieve early diagnosis of patients at risk, which is the fundamental premise to achieve lower fetal and neonatal morbidity and mortality.


Subject(s)
Vasa Previa , Umbilical Cord
11.
Article in Chinese | WPRIM | ID: wpr-828925

ABSTRACT

OBJECTIVE@#To study the anti- fibrotic effect of human umbilical cord mesenchymal stem cell-derived exosomes (hUCMSC-EXOs) and explore the mechanism.@*METHODS@#Twenty-four C57 BL/6 mice were divided into 4 groups (=6), including the control group treated with intratracheal injection of saline (3 mg/kg); lung fibrosis model group with intratracheal injection of 1.5 mg/mL bleomycin solution (prepared with saline, 3 mg/kg); EXOs1 group with intratracheal injection of 1.5 mg/mL bleomycin solution (3 mg/kg) and hUCMSC-EXOs (100 μg/250 μL, given by tail vein injection on the next day after modeling); and EXOs2 group with intratracheal injection of 1.5 mg/mL bleomycin solution (3 mg/kg) and hUCMSC-EXOs (100 μg/250 μL, given by tail vein injection on the 10th day after modeling). At 21 days after modeling, pulmonary index, lung tissue pathology and collagen deposition in the mice were assessed using HE staining and Masson staining. The expression level of TGF-β1 was detected using ELISA, and vimentin, E-cadherin and phosphorylated Smad2/3 (p-Smad2/3) were detected using immunohistochemical staining. CCK8 assay was used to evaluate the effect of hUCMSCEXOs on the viability of A549 cells, and Western blotting was used to detect the expression levels of p-Smad2/3, vimentin, and E-cadherin in the cells.@*RESULTS@#Compared with those in the model group, the mice treated with hUCMSC-EXOs showed significantly reduced the pulmonary index ( < 0.05), collagen deposition, lung tissue pathologies, lowered expressions of TGF-β1 ( < 0.05), vimentin, and p-Smad2/3 and increased expression of E-cadherin. hUCMSC-EXOs given on the second day produced more pronounced effect than that given on the 11th day ( < 0.05). CCK8 assay results showed that hUCMSC-EXOs had no toxic effects on A549 cells ( > 0.05). Western blotting results showed that hUCMSC-EXOs treatment significantly increased the expression of E-cadherin and decreased the expressions of p-Smad2/3 and vimentin in the cells.@*CONCLUSIONS@#hUCMSC-EXOs can alleviate pulmonary fibrosis in mice by inhibiting epithelialmesenchymal transition activated by the TGF-β1/Smad2/3 signaling pathway, and the inhibitory effect is more obvious when it is administered on the second day after modeling.


Subject(s)
Animals , Epithelial-Mesenchymal Transition , Exosomes , Humans , Mesenchymal Stem Cells , Mice , Pulmonary Fibrosis , Transforming Growth Factor beta1 , Umbilical Cord
12.
Article in Chinese | WPRIM | ID: wpr-828506

ABSTRACT

OBJECTIVE@#To study the anti- fibrotic effect of human umbilical cord mesenchymal stem cell-derived exosomes (hUCMSC-EXOs) and explore the mechanism.@*METHODS@#Twenty-four C57 BL/6 mice were divided into 4 groups (=6), including the control group treated with intratracheal injection of saline (3 mg/kg); lung fibrosis model group with intratracheal injection of 1.5 mg/mL bleomycin solution (prepared with saline, 3 mg/kg); EXOs1 group with intratracheal injection of 1.5 mg/mL bleomycin solution (3 mg/kg) and hUCMSC-EXOs (100 μg/250 μL, given by tail vein injection on the next day after modeling); and EXOs2 group with intratracheal injection of 1.5 mg/mL bleomycin solution (3 mg/kg) and hUCMSC-EXOs (100 μg/250 μL, given by tail vein injection on the 10th day after modeling). At 21 days after modeling, pulmonary index, lung tissue pathology and collagen deposition in the mice were assessed using HE staining and Masson staining. The expression level of TGF-β1 was detected using ELISA, and vimentin, E-cadherin and phosphorylated Smad2/3 (p-Smad2/3) were detected using immunohistochemical staining. CCK8 assay was used to evaluate the effect of hUCMSCEXOs on the viability of A549 cells, and Western blotting was used to detect the expression levels of p-Smad2/3, vimentin, and E-cadherin in the cells.@*RESULTS@#Compared with those in the model group, the mice treated with hUCMSC-EXOs showed significantly reduced the pulmonary index ( < 0.05), collagen deposition, lung tissue pathologies, lowered expressions of TGF-β1 ( < 0.05), vimentin, and p-Smad2/3 and increased expression of E-cadherin. hUCMSC-EXOs given on the second day produced more pronounced effect than that given on the 11th day ( < 0.05). CCK8 assay results showed that hUCMSC-EXOs had no toxic effects on A549 cells ( > 0.05). Western blotting results showed that hUCMSC-EXOs treatment significantly increased the expression of E-cadherin and decreased the expressions of p-Smad2/3 and vimentin in the cells.@*CONCLUSIONS@#hUCMSC-EXOs can alleviate pulmonary fibrosis in mice by inhibiting epithelialmesenchymal transition activated by the TGF-β1/Smad2/3 signaling pathway, and the inhibitory effect is more obvious when it is administered on the second day after modeling.


Subject(s)
Animals , Epithelial-Mesenchymal Transition , Exosomes , Gene Expression Profiling , Gene Expression Regulation , Humans , Mesenchymal Stem Cells , Cell Biology , Mice , Pulmonary Fibrosis , Therapeutics , Transforming Growth Factor beta1 , Genetics , Umbilical Cord , Cell Biology
13.
Journal of Experimental Hematology ; (6): 1363-1366, 2020.
Article in Chinese | WPRIM | ID: wpr-827111

ABSTRACT

OBJECTIVE@#To explore the appropriate procedures for preparing extracellular microvesicles (MV) derived from human mesenchymal stem cells (MSC).@*METHODS@#Human MSCs from umbilical cords were cultured in a serum-free medium and maintained in a basal medium for 72 hours after the cell confluence reached to 80%. The supernatants of cultured cells were collected and MVs were enriched. MVs were identified by flow cytometry and electron microscopy. The total protein amount in MVs was used as a parameter for the content of MVs. The supernatants were adjusted to different pH values, and the output of MVs was detected. The supernatants were also collected for enriching the MV and detecting the protein content of MV after the cells were maintained in the basic medium for different time.@*RESULTS@#Flow cytometric analysis showed that the MVs expressed CD9, CD63 and CD81, morphologically presented round under an electron microscope and the diameter of MV was around 100 nm. After enrichment of MV, the protein content of MVs in the supernatants was 416.8±128.1, 255.4±77.9 and 142.8±46.4 μg per 10 MSC,respectively at pH of supernatant 3, 7 and 9 (P<0.05). The protein content of the supernatants per 10 MSC was 173.6±44.5, 262.4±49.6 and 364.2±37.8 μg respectively after starvation culture for 48, 72 and 96 hrs (P<0.05).@*CONCLUSION@#MVs can be readily collected after MSCs were starved for 96 hours, and the pH of the supernatants is adjusted at 3.0.


Subject(s)
Cell-Derived Microparticles , Cells, Cultured , Flow Cytometry , Humans , Mesenchymal Stem Cells , Umbilical Cord
14.
Acta Physiologica Sinica ; (6): 426-432, 2020.
Article in Chinese | WPRIM | ID: wpr-827045

ABSTRACT

The purpose of the present study was to investigate the effects of forkhead box O4 (FOXO4) on the senescence of human umbilical cord-derived mesenchymal stem cells (hUC-MSCs). The hUC-MSCs were induced to senescence by natural passage, and FOXO4 expression was inhibited by lentiviral shRNA transfection. The hallmark of cell senescence was analyzed by β-galactosidase staining, and the cell viability was assayed by CCK-8 method. Flow cytometry was used to investigate the apoptosis of hUC-MSCs. The expression levels of Bcl-2, Bax, FOXO4, interleukin 6 (IL-6) and cleaved Caspase-3 were detected by qPCR and Western blot. Immunofluorescence staining was used to detect FOXO4 expression. The amount of IL-6 secreted by hUC-MSCs was detected by ELISA. The results showed that, compared with the passage 1, senescent hUC-MSCs showed up-regulated expression levels of Bax and FOXO4, down-regulated expression levels of Bcl-2 and cleaved Caspase-3, and increased IL-6 mRNA expression and secretion. FOXO4 inhibition in senescent hUC-MSCs promoted cell apoptosis, reduced cell viability, and inhibited the mRNA expression and secretion of IL-6. These results suggest that FOXO4 maintains viability and function of senescent hUC-MSCs by repressing their apoptosis response, thus accelerating senescence of the whole cell colony.


Subject(s)
Apoptosis , Cell Cycle Proteins , Cell Survival , Cellular Senescence , Forkhead Transcription Factors , Humans , Mesenchymal Stem Cell Transplantation , Mesenchymal Stem Cells , Transcription Factors , Umbilical Cord
15.
Article in English | WPRIM | ID: wpr-877687

ABSTRACT

INTRODUCTION@#Pregnant women are reported to be at increased risk of severe coronavirus disease 2019 (COVID-19) due to underlying immunosuppression during pregnancy. However, the clinical course of COVID-19 in pregnancy and risk of vertical and horizontal transmission remain relatively unknown. We aim to describe and evaluate outcomes in pregnant women with COVID-19 in Singapore.@*METHODS@#Prospective observational study of 16 pregnant patients admitted for COVID-19 to 4 tertiary hospitals in Singapore. Outcomes included severe disease, pregnancy loss, and vertical and horizontal transmission.@*RESULTS@#Of the 16 patients, 37.5%, 43.8% and 18.7% were infected in the first, second and third trimesters, respectively. Two gravidas aged ≥35 years (12.5%) developed severe pneumonia; one patient (body mass index 32.9kg/m2) required transfer to intensive care. The median duration of acute infection was 19 days; one patient remained reverse transcription polymerase chain reaction (RT-PCR) positive >11 weeks from diagnosis. There were no maternal mortalities. Five pregnancies produced term live-births while 2 spontaneous miscarriages occurred at 11 and 23 weeks. RT-PCR of breast milk and maternal and neonatal samples taken at birth were negative; placenta and cord histology showed non-specific inflammation; and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific immunoglobulins were elevated in paired maternal and umbilical cord blood (n=5).@*CONCLUSION@#The majority of COVID-19 infected pregnant women had mild disease and only 2 women with risk factors (obesity, older age) had severe infection; this represents a slightly higher incidence than observed in age-matched non-pregnant women. Among the women who delivered, there was no definitive evidence of mother-to-child transmission via breast milk or placenta.


Subject(s)
Abortion, Spontaneous/epidemiology , Adult , COVID-19/transmission , COVID-19 Nucleic Acid Testing , COVID-19 Serological Testing , Cohort Studies , Disease Transmission, Infectious/statistics & numerical data , Female , Fetal Blood/immunology , Humans , Infectious Disease Transmission, Vertical/statistics & numerical data , Live Birth/epidemiology , Maternal Age , Milk, Human/virology , Obesity, Maternal/epidemiology , Placenta/pathology , Pregnancy , Pregnancy Complications, Infectious/physiopathology , Pregnancy Outcome/epidemiology , Pregnancy Trimester, First , Pregnancy Trimester, Second , Prospective Studies , RNA, Viral/analysis , Risk Factors , SARS-CoV-2 , Severity of Illness Index , Singapore/epidemiology , Umbilical Cord/pathology , Young Adult
16.
Einstein (Säo Paulo) ; 18: eAO5236, 2020. graf
Article in English | LILACS | ID: biblio-1133772

ABSTRACT

ABSTRACT Objective To follow the expansion of mesenchymal stem cells from umbilical cords by two classic senescence markers, p16 (INK4A) and p21 (CDKN1A), using practical, fast, and less expensive methods than the gold standard Western blotting technique, to evaluate its applicability in the laboratory. Methods Mesenchymal stem cells from umbilical cords were isolated from Wharton's jelly and, after quality control, morphological and immunophenotypic characterization by flow cytometry, were expanded in culture until coming close to cell cycle arrest (replicative senescence). Results A comparison was made between young cells, at passage 5, and pre-senescent cells, at passage 10, evaluating the protein expression of the classic cell senescence markers p16 and p21, comparing the results obtained by Western blotting with those obtained by flow cytometry and indirect immunofluorescence. Conclusion Follow-up of cell cultures, through indirect p16 immunofluorescence, allows the identification of mesenchymal stem cells from umbilical cord cultures at risk of reaching replicative senescence.


RESUMO Objetivo Acompanhar a expansão de células-tronco mesenquimais de cordão umbilical por dois marcadores clássicos de senescência, p16 (INK4A) e p21 (CDKN1A), usando métodos práticos, rápidos e com custo menor do que a técnica padrão-ouro de Western blotting, para avaliar sua aplicabilidade em laboratório. Métodos Células-tronco mesenquimais de cordão umbilical foram isoladas da geleia de Wharton e, após controle de qualidade e caracterização morfológica e imunofenotípica por citometria de fluxo, foram expandidas em cultura, até chegarem próximas à parada do ciclo celular (senescência replicativa). Resultados Foi feita a comparação entre células jovens, na passagem 5, e células pré-senescentes, na passagem 10, avaliando a expressão proteica dos marcadores clássicos de senescência celular p16 e p21, comparando os resultados obtidos por Western blotting com os obtidos por citometria de fluxo e imunofluorescência indireta. Conclusão O seguimento de culturas celulares, por meio da imunofluorescência indireta de p16, permite identificar as culturas de células-tronco mesenquimais de cordão umbilical em risco de atingirem a senescência replicativa.


Subject(s)
Humans , Umbilical Cord/physiology , Fluorescent Antibody Technique/methods , Cellular Senescence , Mesenchymal Stem Cells/physiology , Flow Cytometry/methods , Biomarkers/blood , Cells, Cultured , Blotting, Western , Cyclin-Dependent Kinase Inhibitor p16 , Cyclin-Dependent Kinase Inhibitor p21
17.
Article in English | LILACS, BBO | ID: biblio-1135549

ABSTRACT

Abstract Objective: To examine the cytotoxicity of calcium hydroxide on human umbilical cord mesenchymal stem cells (HUCMSC) to understand the characteristics for use in regenerative dentistry procedures especially regenerative endodontics. Material and Methods: HUCMSC was isolated, cultured, and confirmed by flow cytometry. The biological characteristics, such as cell morphology, proliferation, and protein expression, were screened. To check the cytotoxicity, HUCMSC was cultured and divided into two groups, the control group (cultured in minimum essential medium (MEM) alpha) and calcium hydroxide group (cultured in MEM alpha and calcium hydroxide). Methyl-thiazole-tetrazolium (MTT) assay was done on different concentrations of calcium hydroxide (0.39 to 25 µg/mL) and the cells were observed and counted. One-way ANOVA test was used with a significance level set at 5%. Results: Flow cytometric analysis confirmed positive of CD73, CD90, CD105, negative of CD45 and CD34. A significant difference was found between the concentration of 6.25 and 3.125 µg/mL (p=0.004). There was no significant difference among 6.25, 12.5 and 25 µg/mL concentrations. There was also no significant difference among 0.39, 0.78, 1.56, and 3.125 µg/mL concentrations. Conclusion: Even though calcium hydroxide is a medicament of choice in clinical endodontics, it decreases the viability of HUCMSC. The lower the concentration of calcium hydroxide, the higher the viability of HUCMSC.


Subject(s)
Humans , Calcium Hydroxide/therapeutic use , Cell Survival , Stem Cell Research , Mesenchymal Stem Cells , Regenerative Endodontics , Umbilical Cord , Analysis of Variance , Indonesia/epidemiology
18.
Article in English | LILACS, BBO | ID: biblio-1135491

ABSTRACT

Abstract Objective: To show the cytotoxicity of Porphyromonas gingivalis lipopolysaccharide (LPS) on human umbilical cord mesenchymal stem cells (HUCMSCs) to better understand the characteristics for its application in regenerative procedures under periodontopathogen LPS influence. Material and Methods: Ultrapure Porphyromonas gingivalis LPS was used in this study. This research used a frozen stock HUCMSCs, previously confirmed by flow cytometry. The biological characteristics, such as cell morphology, proliferation, and protein expression, were screened. To check the cytotoxicity, HUCMSCs were cultured and divided into two groups, the control group and LPS group with various concentrations from 25 to 0.39 µg/mL. MTT assay was done and the cells were observed and counted. The significance level was set at 5%. Results: The percentage of living HUCMSCs on LPS group were not significantly different among concentrations (p>0.05) from 25 to 0.39 µg/mL, even though there were slight mean decrease between groups, but they were not significant. The duration of 24 hours of exposure of LPS does not significantly lower HUCMSCs viability. Conclusion: LPS does not affect the viability of HUCMSCs. The lower the concentration of LPS, the higher the viability of HUCMSCs.


Subject(s)
Humans , Umbilical Cord , Lipopolysaccharides , Porphyromonas gingivalis , Cytotoxicity, Immunologic/immunology , Mesenchymal Stem Cells , Analysis of Variance , Flow Cytometry , Indonesia/epidemiology
19.
Enferm. foco (Brasília) ; 11(4): 208-213, dez. 2020. tab
Article in Portuguese | LILACS, BDENF | ID: biblio-1146780

ABSTRACT

Objetivo: identificar e sintetizar as evidências disponíveis na literatura sobre o clampeamento do cordão umbilical, e seus resultados evidenciados pela prática. Método: Revisão integrativa da literatura sistematizada em seis etapas, utilizando as bases de dados LILACS, MEDLINE e IBECS e descritores próprios. O período selecionado foi de 2012 a 2018. Resultados: Foram identificados 119 estudos, com uma amostra final composta por 10 estudos selecionados para atender o objetivo proposto. Os estudos apontaram benefícios em relação ao clampeamento tardio do cordão umbilical quando comparado ao clampeamento imediato, tanto em curto prazo, quanto a logo prazo. Conclusão: O clampeamento tardio do cordão umbilical é uma intenção segura de baixo custo e eficaz, e que deve ser incentivada e apoiada no cenário do nascimento. (AU)


Objective: To identify and synthesize the evidence available in literature on umbilical cord clamping, and its results evidenced by practice. Method: Integrative review systematized of literature by six steps using the databases LILACS, MEDLINE e IBECS and own descriptors. Results: Found 119 studs, with a final sample consisting of 10 studies selected to meet the propsed objective. Studies have shown benefits over delayed cord clamping compared to immediate cord clamping. Conclusion: Delayed cord clamping it´s a feature effective and cost effective and should be encouraged and supported. (AU)


Objetivo: identificar y sintetizar la evidencia disponible en la literatura sobre el pinzamiento del cordón umbilical, y sus resultados evidenciados por la práctica. Metodo: Revisión integral sistematizada de la literatura, em seis passos, utilizando las bases de datos LILACS, MEDLINE e IBECS y sus descriptores. Resultados: Se encontraram 119 estudios, con uma muestra final que consta 10 estudios seleccionados para cumplir el objetivo propuesto. Los estudios han demostrado beneficios sobre el pinzamiento tardío del cordón umbilical en comparación con el pinzamiento inmediato. Conclusión: El pinzamento tardio del cordón umbilical es uma intención segura, económica y efectiva que debe fomentarse y apoyarse em el parto. (AU)


Subject(s)
Constriction , Umbilical Cord , Parturition
20.
Braz. arch. biol. technol ; 63: e20200082, 2020. tab, graf
Article in English | LILACS | ID: biblio-1132241

ABSTRACT

Abstract Fluorescent nanodiamond (FND) has been used for long-term cell labeling and in vivo cell tracking because they have good at photostability and biocompatibility. In this study, we evaluate the effect of fluorescent nanodiamond labeling on in vitro culture and differentiation of human umbilical cord mesenchymal stem cells (hUCMSCs) into hepatocyte-like cells (HLCs). For hepatic differentiation of hUCMSCs, cells were induced with human hepatocyte growth factor, nicotinamide and Dexamethasone. FND was supplied in two experimental groups with 20 μg/mL and 100 μg/mL in 2 hours. The cell was assessed for FND uptake by laser scan microscopy and flow cytometry methods. The effect of FND on hUCMSCs was evaluated by the cell viability and growth assays as well as the differentiation throughout of morphology alterations or gene expression of anfa-fetoprotein, albumin, and hepatocyte nuclear factor 4α. The results showed that the labeling of hUCMSCs is efficient and easy and there was significant cellular uptake of FND. We did not observe any negative impacts of FND to the cell viability and growth. FND can be utilized for the long-term labeling and tracking of hUCSCs and HLCs in vivo studies.


Subject(s)
Humans , Umbilical Cord/cytology , Cell Differentiation , Hepatocytes/cytology , Mesenchymal Stem Cells/cytology , Cell Survival , Reverse Transcriptase Polymerase Chain Reaction
SELECTION OF CITATIONS
SEARCH DETAIL